LINC01623: A Potential Drug Target and Biomarker (G401242)

Target Name: LINC01623

NCBI ID: G401242

LINC01623

Other Name(s): Long intergenic non-protein coding RNA 1623 | long intergenic non-protein coding RNA 1623

LINC01623: A Potential Drug Target and Biomarker

LINC01623 is a long intergenic non-protein coding RNA (lncRNA) that has been identified using RNA sequencing (RNA-seq) experiments. This RNA has been shown to play a role in various cellular processes, including cell adhesion, migration, and survival. Its function as a non-protein coding RNA (ncRNA) has been annotated as a potential drug target and biomarker. In this article, we will provide an overview of LINC01623, its potential drug target properties, and its potential as a biomarker for various diseases.

Potential Drug Target

The discovery of LINC01623 as a potential drug target comes from its function as a non-coding RNA. LncRNAs have been shown to play a crucial role in post-transcriptional regulation, which includes the regulation of protein synthesis, degradation, and localization. LINC01623 has been shown to regulate the translation of a protein called PLT2, which is involved in platelet function and thrombosis.

Additionally, LINC01623 has been shown to regulate the expression of genes involved in cell adhesion, migration, and survival. For example, LINC01623 has been shown to repress the expression of the gene encoding the protein E-cadherin, which is involved in cell-cell adhesion. This suggests that LINC01623 may have a negative impact on the development of cancer cell, which could make it a potential drug target.

Potential Biomarker

LINC01623 has also been shown to have potential as a biomarker for various diseases. For example, LINC01623 has been shown to be downregulated in various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Additionally, LINC01623 has been shown to be upregulated in diseases associated with inflammation, such as rheumatoid arthritis and inflammatory bowel disease.

Furthermore, LINC01623 has been shown to be involved in the regulation of cellular processes that are associated with aging, such as the regulation of telomere length and the DNA damage response. This suggests that LINC01623 may be a potential biomarker for age-related diseases.

Conclusion

In conclusion, LINC01623 is a long intergenic non-protein coding RNA that has been shown to play a role in various cellular processes. Its function as a non-protein coding RNA has been annotated as a potential drug target and biomarker. Further studies are needed to fully understand the function of LINC01623 and its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1623

The "LINC01623 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01623 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets